Treatment De-Intensification and Residual HIV-1 in Adolescents and Young Adults: A Sub-Study of ATN 061 and ATN 071.
Phase of Trial: Phase II
Latest Information Update: 02 Mar 2017
At a glance
- Drugs Atazanavir (Primary) ; Antiretrovirals
- Indications HIV-1 infections
- Focus Pharmacogenomic; Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 05 Dec 2011 Actual patient number is 34 according to ClinicalTrials.gov.
- 05 Dec 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.